Lirong Zhao

TL;DR: Evidence is provided that racial/ethnic disparities in utilization of drugs used to treat dementia exist and are not accounted for by differences in demographic, economic, health status, or health utilization factors.

TL;DR: This study provides no evidence of increased hospital events or mortality in LTC residents who use AP medications, and contribute to a growing body of evidence that APs, particularly atypical agents, may be associated with reduced mortality inLTC residents.

TL;DR: An economic case for promoting greater persistency in use of drugs with approved indications by Medicare beneficiaries with diabetes is suggested; however, additional research is needed to corroborate the study's cross-sectional findings.

TL;DR: It is found that the utilization of health care resources and economic burden of LTC residents with COPD were primarily due to LTC, pharmacy, and inpatient costs.

TL;DR: Obese individuals had higher utilization rates for selected medications used to treat diabetes, hypertension, ischemic heart disease, heart failure, hyperlipidemia, and osteoarthritis, and prescription drug coverage is also a significant factor.